$CIX
COMPX INTERNATIONAL INC

2021 Q3 Form 10-Q Financial Statement

#000156459021053971 Filed on November 03, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2020 Q3
Revenue $34.56M $28.40M
YoY Change 21.68% -4.38%
Cost Of Revenue $23.63M $21.10M
YoY Change 12.02% 4.31%
Gross Profit $10.92M $7.300M
YoY Change 49.62% -23.16%
Gross Profit Margin 31.61% 25.7%
Selling, General & Admin $5.791M $5.246M
YoY Change 10.39% 0.69%
% of Gross Profit 53.02% 71.86%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $961.0K $960.0K
YoY Change 0.1% 3.23%
% of Gross Profit 8.8% 13.15%
Operating Expenses $5.791M $5.246M
YoY Change 10.39% 0.69%
Operating Profit $5.131M $2.100M
YoY Change 144.33% -51.16%
Interest Expense $289.0K $360.0K
YoY Change -19.72% -57.55%
% of Operating Profit 5.63% 17.14%
Other Income/Expense, Net
YoY Change
Pretax Income $5.420M $2.442M
YoY Change 121.95% -52.25%
Income Tax $1.288M $610.0K
% Of Pretax Income 23.76% 24.98%
Net Earnings $4.132M $1.800M
YoY Change 129.56% -53.85%
Net Earnings / Revenue 11.96% 6.34%
Basic Earnings Per Share $0.33
Diluted Earnings Per Share $333.1K $147.1K
COMMON SHARES
Basic Shares Outstanding 12.41M
Diluted Shares Outstanding 12.41M

Balance Sheet

Concept 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $75.96M $65.08M
YoY Change 16.73% 29.57%
Cash & Equivalents $75.96M $65.08M
Short-Term Investments
Other Short-Term Assets $3.056M $1.254M
YoY Change 143.7% -25.36%
Inventory $23.54M $19.17M
Prepaid Expenses
Receivables $15.11M $12.28M
Other Receivables $0.00 $0.00
Total Short-Term Assets $117.7M $97.77M
YoY Change 20.34% 16.17%
LONG-TERM ASSETS
Property, Plant & Equipment $28.54M $29.36M
YoY Change -2.79% -5.94%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $21.80M $30.50M
YoY Change -28.52% -16.89%
Other Assets $598.0K $590.0K
YoY Change 1.36% 0.0%
Total Long-Term Assets $74.68M $84.19M
YoY Change -11.3% -8.73%
TOTAL ASSETS
Total Short-Term Assets $117.7M $97.77M
Total Long-Term Assets $74.68M $84.19M
Total Assets $192.3M $182.0M
YoY Change 5.7% 3.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.502M $2.693M
YoY Change 67.17% -23.01%
Accrued Expenses $9.792M $8.382M
YoY Change 16.82% -4.92%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $15.69M $11.73M
YoY Change 33.68% -10.65%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $15.69M $11.73M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $19.35M $15.22M
YoY Change 27.14% -8.18%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $173.0M $166.7M
YoY Change
Total Liabilities & Shareholders Equity $192.3M $182.0M
YoY Change 5.7% 3.15%

Cashflow Statement

Concept 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income $4.132M $1.800M
YoY Change 129.56% -53.85%
Depreciation, Depletion And Amortization $961.0K $960.0K
YoY Change 0.1% 3.23%
Cash From Operating Activities $4.534M $4.300M
YoY Change 5.44% -34.12%
INVESTING ACTIVITIES
Capital Expenditures -$668.0K -$430.0K
YoY Change 55.35% -33.02%
Acquisitions
YoY Change
Other Investing Activities $4.200M $0.00
YoY Change -100.0%
Cash From Investing Activities $3.532M -$430.0K
YoY Change -921.4% -116.22%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -2.481M -1.245M
YoY Change 99.28% 42.94%
NET CHANGE
Cash From Operating Activities 4.534M 4.300M
Cash From Investing Activities 3.532M -430.0K
Cash From Financing Activities -2.481M -1.245M
Net Change In Cash 5.585M 2.625M
YoY Change 112.76% -68.4%
FREE CASH FLOW
Cash From Operating Activities $4.534M $4.300M
Capital Expenditures -$668.0K -$430.0K
Free Cash Flow $5.202M $4.730M
YoY Change 9.98% -34.02%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Treasury Stock Value Acquired Par Value Method
TreasuryStockValueAcquiredParValueMethod
755000
us-gaap Net Income Loss
NetIncomeLoss
8168000
us-gaap Net Income Loss
NetIncomeLoss
13437000
CY2020Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.10
cix Adjustments To Additional Paid In Capital Stock Issued
AdjustmentsToAdditionalPaidInCapitalStockIssued
104000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
166747000
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
7452000
CY2021Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.20
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
172990000
CY2020Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1245000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
166747000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
171339000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
4132000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
172990000
us-gaap Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
22828000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3691000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1820000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5322000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
65075000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
75959000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3734000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
755000
us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
25228000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3734000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-8207000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2767000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3361000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
106733000
us-gaap Operating Income Loss
OperatingIncomeLoss
16706000
cix Interest Income From Related Party And Dividend Income
InterestIncomeFromRelatedPartyAndDividendIncome
945000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
17651000
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
70000
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
15106000
CY2021Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
4996000
CY2021Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
15048000
CY2021Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
3492000
CY2021Q3 us-gaap Inventory Net
InventoryNet
23536000
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8137000
CY2020Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
301000
CY2020Q4 cix Accrued Customer Tooling Cost
AccruedCustomerToolingCost
393000
CY2021Q3 cix Accrued Customer Tooling Cost
AccruedCustomerToolingCost
527000
CY2021Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
540000
CY2021Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
14294000
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
3707000
us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
570000
cix Income Tax Reconciliation Foreign Derived Intangible Income Benefit
IncomeTaxReconciliationForeignDerivedIntangibleIncomeBenefit
-73000
us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
10000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4214000
CY2021Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
50000000
CY2021Q1 us-gaap Treasury Stock Value Acquired Par Value Method
TreasuryStockValueAcquiredParValueMethod
755000
CY2021Q3 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
627547000

Files In Submission

Name View Source Status
0001564590-21-053971-index-headers.html Edgar Link pending
0001564590-21-053971-index.html Edgar Link pending
0001564590-21-053971.txt Edgar Link pending
0001564590-21-053971-xbrl.zip Edgar Link pending
cix-10q_20210930.htm Edgar Link pending
cix-10q_20210930_htm.xml Edgar Link completed
cix-20210930.xsd Edgar Link pending
cix-20210930_cal.xml Edgar Link unprocessable
cix-20210930_def.xml Edgar Link unprocessable
cix-20210930_lab.xml Edgar Link unprocessable
cix-20210930_pre.xml Edgar Link unprocessable
cix-ex311_13.htm Edgar Link pending
cix-ex312_12.htm Edgar Link pending
cix-ex321_11.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending